Press Release: BB Biotech AG : Publication pursuant to --26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution

BB Biotech AG / BB Biotech AG : Publication pursuant to --26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Pursuant to article 26a WpHG, BB Biotech AG, Schwertstrasse 6, 8200 Schaffhausen, Switzerland, hereby announces that the total voting rights from July 12, 2016 amount to 55 400 000.

For further information please contact: Bellevue Asset Management AG, Seestrasse 16,

8700 Küsnacht / Zurich

Tanja Chicherio, Tel. +41 44 267 67 00.

Media release: http://hugin.info/136834/R/2028674/754201.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: BB Biotech AG via Globenewswire

HUG#2028674

--- End of Message ---

BB Biotech AG

Schwertstrasse 6 Schaffhausen Switzerland

WKN: 888509;ISIN: CH0038389992;Index:HDAX,MIDCAP,TecDAX,TECH All Share, Prime All Share;

Listed: Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.bbbiotech.com (END) Dow Jones Newswires

   July 14, 2016 11:40 ET (15:40 GMT)- - 11 40 AM EDT 07-14-16